Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:751-760
Published online before print August 21, 2008, doi: 10.1161/CIRCRESAHA.108.175083
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/7/751    most recent
CIRCRESAHA.108.175083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foubert, P.
Right arrow Articles by Tobelem, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foubert, P.
Right arrow Articles by Tobelem, G.
Related Collections
Right arrow Angiogenesis
Right arrowRelated Article
(Circulation Research. 2008;103:751.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Coadministration of Endothelial and Smooth Muscle Progenitor Cells Enhances the Efficiency of Proangiogenic Cell-Based Therapy

Philippe Foubert, Gianfranco Matrone, Boussad Souttou, Carole Leré-Déan, Véronique Barateau, Jean Plouët, Sophie Le Ricousse-Roussanne, Bernard I. Lévy, Jean-Sébastien Silvestre, Gérard Tobelem

From the Institut des Vaisseaux et du Sang (P.F., B.S., C.L.-D., J.P., S.L.R.-R., G.T.), Paris; and Cardiovascular Research Center (J.-S.S., G.M., V.B., J.P., B.I.L.), Institut National de la Santé et de la Recherche Médicale Lariboisière U689, Université Paris 7, Hôpital Lariboisière, Paris, France.

Correspondence to Gérard Tobelem, Institut des Vaisseaux et du Sang, 8 rue Guy Patin, 75475 Paris Cedex 10, France. E-mail gerard.tobelem{at}lrb.aphp.fr

Cell-based therapy is a promising approach designed to enhance neovascularization and function of ischemic tissues. Interaction between endothelial and smooth muscle cells regulates vessels development and remodeling and is required for the formation of a mature and functional vascular network. Therefore, we assessed whether coadministration of endothelial progenitor cells (EPCs) and smooth muscle progenitor cells (SMPCs) can increase the efficiency of cell therapy. Unilateral hindlimb ischemia was surgically induced in athymic nude mice treated with or without intravenous injection of EPCs (0.5x106), SMPCs (0.5x106) and EPCs+SMPCs (0.25x106+0.25x106). Vessel density and foot perfusion were increased in mice treated with EPCs+SMPCs compared to animals receiving EPCs alone or SMPCs alone (P<0.001). In addition, capillary and arteriolar densities were enhanced in EPC+SMPC–treated mice compared to SMPC and EPC groups (P<0.01). We next examined the role of Ang-1/Tie2 signaling in the beneficial effect of EPC and SMPC coadministration. Small interfering RNA directed against Ang-1–producing SMPCs or Tie2-expressing EPCs blocked vascular network formation in Matrigel coculture assays, reduced the rate of incorporated EPCs within vascular structure, and abrogated the efficiency of cell therapy. Production of Ang-1 by SMPCs activates Tie2-expressing EPCs, resulting in increase of EPC survival and formation of a stable vascular network. Subsequently, the efficiency of EPC- and SMPC-based cotherapy is markedly increased. Therefore, coadministration of different types of vascular progenitor cells may constitute a novel therapeutic strategy for improving the treatment of ischemic diseases.


Key Words: angiogenesis • progenitor cells • ischemia • angiopoietin-1 • Tie2


Related Article:

Biological Surgery: Synergetic Angiogenic Therapy Using Coadministration of Two Progenitor Cell Populations
Wei Li and Roy L. Silverstein
Circ. Res. 2008 103: 684-686. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Nickerson, J. Song, J. K. Meisner, S. Bajikar, C. W. Burke, C. W. Shuptrine, G. K. Owens, T. C. Skalak, and R. J. Price
Bone Marrow-Derived Cell-Specific Chemokine (C-C Motif) Receptor-2 Expression is Required for Arteriolar Remodeling
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1794 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Li and R. L. Silverstein
Biological Surgery: Synergetic Angiogenic Therapy Using Coadministration of Two Progenitor Cell Populations
Circ. Res., September 26, 2008; 103(7): 684 - 686.
[Full Text] [PDF]